DelveInsight

Oct 06, 2017

C-X-C Chemokine Receptor Inhibitors–The Emerging Therapeutic Agents

Sep 28, 2017

Alzeimer’s drug; Guardant Health receives approval; First Patient Dosed in Phase 1 Clinical Trial; Sunny Pharmtech and Vitruvias Therapeutics Receive FDA Approval

Sep 22, 2017

Isocitrate dehydrogenase (IDH) inhibitors– Emerging Anti-Cancer Therapeutics

Sep 20, 2017

Business Cocktail

Sep 18, 2017

Oral Mucositis – A Common Cancer Therapy Adverse Reaction

Sep 15, 2017

Business cocktail

Aug 09, 2017

Genetically Engineered Salmon : Are you up for dinner?

Jul 25, 2017

Remicade’s launch; Endo cuts jobs; Analysts downgrade Pfizer; Corning $500M glass project

Jul 18, 2017

Takeda scores; PhRMA launches; Valeant’s Obagi; Ex-Novo executive signs

Jul 12, 2017

Georgia physician to lead US public-health agency

Newsletter/Whitepaper